{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:33:49Z","timestamp":1771554829815,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017661","name":"China Health Promotion Foundation","doi-asserted-by":"crossref","award":["XM_2020_011_0245_09"],"award-info":[{"award-number":["XM_2020_011_0245_09"]}],"id":[{"id":"10.13039\/501100017661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81800601"],"award-info":[{"award-number":["81800601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2019M652333"],"award-info":[{"award-number":["2019M652333"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao Medical and Health Research Guidance Project","award":["2023-WJZD066"],"award-info":[{"award-number":["2023-WJZD066"]}]},{"name":"\"Clinical Medicine +X\" Research Project of Affiliated Hospital of Qingdao University","award":["QDFY+X2023210"],"award-info":[{"award-number":["QDFY+X2023210"]}]},{"DOI":"10.13039\/100019558","name":"Qingdao Key Health Discipline Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019558","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao Key Clinical Specialty Elite Discipline"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07600-5","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:39:22Z","timestamp":1745246362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of belimumab in recurrent spontaneous abortions amongst patients with lymphocyte dysfunction: a retrospective case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lijuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"7600_CR1","doi-asserted-by":"crossref","unstructured":"Thornton P, Douglas J. Coagulation in pregnancy. Best practice & research Clinical obstetrics & gynaecology. 2010;24(3):339\u201352.","DOI":"10.1016\/j.bpobgyn.2009.11.010"},{"issue":"7","key":"7600_CR2","first-page":"671","volume":"33","author":"S Wu","year":"2017","unstructured":"Wu S, Zhang J. Anticoagulation therapy for recurrent spontaneous abortion. Chin J Practical Gynecol Obstet. 2017;33(7):671\u20135.","journal-title":"Chin J Practical Gynecol Obstet"},{"key":"7600_CR3","doi-asserted-by":"publisher","first-page":"717630","DOI":"10.3389\/fendo.2021.717630","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, Bi S, Fu J, Qi L, Li L, Fu Y. Retrospective analysis of Fondaparinux and Low-Molecular-Weight heparin in the treatment of women with recurrent spontaneous abortion. Front Endocrinol. 2021;12:717630.","journal-title":"Front Endocrinol"},{"key":"7600_CR4","doi-asserted-by":"publisher","first-page":"789829","DOI":"10.3389\/fphys.2021.789829","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, Fu J, Ding F, Liu J, Li L, Song Q, et al. IL-33 and soluble ST2 are associated with recurrent spontaneous abortion in early pregnancy. Front Physiol. 2021;12:789829.","journal-title":"Front Physiol"},{"issue":"1","key":"7600_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-016-8586-z","volume":"53","author":"A Deroux","year":"2017","unstructured":"Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female infertility and serum Auto-antibodies: a systematic review. Clin Rev Allergy Immunol. 2017;53(1):78\u201386.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"7600_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00228-023-03473-9","volume":"79","author":"J Liu","year":"2023","unstructured":"Liu J, Li M, Fu J, Yuan G, Li N, Fu Y, et al. Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial. Eur J Clin Pharmacol. 2023;79(5):627\u201334.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"7600_CR7","first-page":"3303","volume":"28","author":"D Li","year":"2021","unstructured":"Li D, Zheng L, Zhao D, Xu Y, Wang Y. The role of immune cells in recurrent spontaneous abortion. Reproductive sciences (Thousand Oaks. Calif). 2021;28(12):3303\u201315.","journal-title":"Calif)"},{"key":"7600_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3389\/fimmu.2019.02317","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang F, Zheng Q, Jin L. Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the Maternal-Fetal interface. Front Immunol. 2019;10:2317.","journal-title":"Front Immunol"},{"issue":"2","key":"7600_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.gpb.2020.11.002","volume":"19","author":"F Wang","year":"2021","unstructured":"Wang F, Jia W, Fan M, Shao X, Li Z, Liu Y, et al. Single-cell immune landscape of human recurrent miscarriage. Genom Proteom Bioinform. 2021;19(2):208\u201322.","journal-title":"Genom Proteom Bioinform"},{"key":"7600_CR10","doi-asserted-by":"crossref","unstructured":"Yang X, Tian Y, Zheng L, Luu T, Kwak-Kim J. The update Immune-Regulatory role of Pro- and Anti-Inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci. 2022;24(1).","DOI":"10.3390\/ijms24010132"},{"issue":"7","key":"7600_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1055\/a-0634-1813","volume":"78","author":"X Zhao","year":"2018","unstructured":"Zhao X, Jiang Y, Wang L, Li Z, Li Q, Feng X. Advances in Understanding the immune imbalance between T-Lymphocyte subsets and NK cells in recurrent spontaneous abortion. Geburtshilfe Frauenheilkd. 2018;78(7):677\u201383.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"7600_CR12","doi-asserted-by":"publisher","first-page":"e12802","DOI":"10.1111\/cpr.12802","volume":"53","author":"Y Ma","year":"2020","unstructured":"Ma Y, Yang Q, Fan M, Zhang L, Gu Y, Jia W, et al. Placental endovascular extravillous trophoblasts (enEVTs) educate maternal T-cell differentiation along the maternal-placental circulation. Cell Prolif. 2020;53(5):e12802.","journal-title":"Cell Prolif"},{"key":"7600_CR13","doi-asserted-by":"crossref","unstructured":"Luan X, Kang X, Li W, Dong Q. An investigation of the relationship between recurrent spontaneous abortion and memory T follicular helper cells. American journal of reproductive immunology (New York, NY: 1989). 2017;78(5).","DOI":"10.1111\/aji.12714"},{"issue":"6","key":"7600_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.12891\/ceog2006.2015","volume":"42","author":"JH Fu","year":"2015","unstructured":"Fu JH. Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion. Clin Exp Obstet Gynecol. 2015;42(6):739\u201342.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"7600_CR15","doi-asserted-by":"publisher","first-page":"774213","DOI":"10.3389\/fphys.2021.774213","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, Qi L, Fu J, Bi S, Li L, Fu Y, Corrigendum. Efficacy of intrauterine perfusion of cyclosporin A for intractable recurrent spontaneous abortion patients with endometrial alloimmune disorders: A randomized controlled trial. Front Physiol. 2021;12:774213.","journal-title":"Front Physiol"},{"issue":"1","key":"7600_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00404-022-06718-7","volume":"308","author":"S Zhang","year":"2023","unstructured":"Zhang S, Han X, Liu W, Wen Q, Wang J. Pregnancy in patients with systemic lupus erythematosus: a systematic review. Arch Gynecol Obstet. 2023;308(1):63\u201371.","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"7600_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"7600_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI38010","volume":"119","author":"MP Cancro","year":"2009","unstructured":"Cancro MP, D\u2019Cruz DP, Khamashta MA. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Investig. 2009;119(5):1066\u201373.","journal-title":"J Clin Investig"},{"issue":"2","key":"7600_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2003;62(2):168\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7600_CR20","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/ar1855","volume":"8","author":"CE Collins","year":"2006","unstructured":"Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Therapy. 2006;8(1):R6.","journal-title":"Arthritis Res Therapy"},{"issue":"12","key":"7600_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1177\/0961203320950461","volume":"29","author":"H Cohen","year":"2020","unstructured":"Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, et al. 16th international Congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends. Lupus. 2020;29(12):1571\u201393.","journal-title":"Lupus"},{"issue":"8","key":"7600_CR22","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/art.23678","volume":"58","author":"M Petri","year":"2008","unstructured":"Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2008;58(8):2453\u20139.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"7600_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/art.23539","volume":"59","author":"R Campbell Jr","year":"2008","unstructured":"Campbell R Jr., Cooper GS, Gilkeson GS. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis Rheum. 2008;59(4):458\u201364.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"7600_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/0961203320947814","volume":"29","author":"A Babini","year":"2020","unstructured":"Babini A, Cappuccio AM, Caprarulo C, Casado G, Eimon A, Figueredo H, et al. Evaluation of Belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: results from a 24-month observe study in Argentina. Lupus. 2020;29(11):1385\u201396.","journal-title":"Lupus"},{"issue":"7","key":"7600_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.192.7.953","volume":"192","author":"RK Do","year":"2000","unstructured":"Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000;192(7):953\u201364.","journal-title":"J Exp Med"},{"issue":"2","key":"7600_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/bdr2.2091","volume":"115","author":"P Juliao","year":"2023","unstructured":"Juliao P, Wurst K, Pimenta JM, Gemzoe K, Landy H, Moody MA, et al. Belimumab use during pregnancy: interim results of the Belimumab pregnancy registry. Birth Defects Res. 2023;115(2):188\u2013204.","journal-title":"Birth Defects Res"},{"key":"7600_CR27","unstructured":"Chinese expert consensus on diagnosis and management of recurrent spontaneous abortion (2022). Zhonghua fu chan ke za zhi. 2022;57(9):653\u2013\u200967."},{"key":"7600_CR28","unstructured":"Guideline for enumeration. of peripheral blood lymphocyte subsets by flow cytometry. People\u2019s Republic of China health industry standard. 2024."},{"key":"7600_CR29","doi-asserted-by":"crossref","unstructured":"Atisha-Fregoso Y, Malkiel S, Harris KM, Byron M, Ding L, Kanaparthi S, et al. Phase II randomized trial of rituximab plus cyclophosphamide followed by Belimumab for the treatment of lupus nephritis. Volume 73. Arthritis & rheumatology; 2021. pp. 121\u201331. (Hoboken, NJ). 1.","DOI":"10.1002\/art.41466"},{"issue":"2","key":"7600_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00404-016-4270-z","volume":"295","author":"MB Cavalcante","year":"2017","unstructured":"Cavalcante MB, Sarno M, Araujo J\u00fanior E, Da Silva Costa F, Barini R. Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis. Arch Gynecol Obstet. 2017;295(2):511\u20138.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"7600_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard-2022-223684","volume":"82","author":"H Bitter","year":"2023","unstructured":"Bitter H, Warren DJ, Bolstad N, Noraas AL, Ostensen ME. Transplacental passage of Belimumab during pregnancy and follow-up of a child exposed in utero. Ann Rheum Dis. 2023;82(4):577\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7600_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ajg.2008.71","volume":"104","author":"SV Kane","year":"2009","unstructured":"Kane SV, Acquah LA. Placental transport of Immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104(1):228\u201333.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"7600_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/1756-185X.14445","volume":"26","author":"SR Wei","year":"2023","unstructured":"Wei SR, Zhu ZZ, Xu J, Mo HY. Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with Belimumab. Int J Rheum Dis. 2023;26(1):154\u20136.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"7600_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.reprotox.2009.07.002","volume":"28","author":"DJ Auyeung-Kim","year":"2009","unstructured":"Auyeung-Kim DJ, Devalaraja MN, Migone TS, Cai W, Chellman GJ. Developmental and peri-postnatal study in cynomolgus monkeys with Belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reproductive Toxicol (Elmsford NY). 2009;28(4):443\u201355.","journal-title":"Reproductive Toxicol (Elmsford NY)"},{"key":"7600_CR35","doi-asserted-by":"crossref","unstructured":"Bag-Ozbek A, Hui-Yuen JS. Emerging B-Cell therapies in systemic lupus erythematosus. Therapeutics and clinical risk management. 2021;17:39\u201354.","DOI":"10.2147\/TCRM.S252592"},{"issue":"2","key":"7600_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semarthrit.2014.05.006","volume":"44","author":"A Danve","year":"2014","unstructured":"Danve A, Perry L, Deodhar A. Use of Belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report. Semin Arthritis Rheum. 2014;44(2):195\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"7600_CR37","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3899\/jrheum.170327","volume":"44","author":"A Kumthekar","year":"2017","unstructured":"Kumthekar A, Danve A, Deodhar A. Use of Belimumab throughout 2 consecutive pregnancies in a patient with systemic lupus erythematosus. J Rhuematol. 2017;44(9):1416\u20137.","journal-title":"J Rhuematol"},{"issue":"6","key":"7600_CR38","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.semarthrit.2016.03.005","volume":"45","author":"G Emmi","year":"2016","unstructured":"Emmi G, Silvestri E, Squatrito D, Mecacci F, Ciampalini A, Emmi L, et al. Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with Belimumab: A confirmation report. Semin Arthritis Rheum. 2016;45(6):e26\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"7600_CR39","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/annrheumdis-2018-213004","volume":"77","author":"H Bitter","year":"2018","unstructured":"Bitter H, Bendvold AN, \u00d8stensen ME. Lymphocyte changes and vaccination response in a child exposed to Belimumab during pregnancy. Ann Rheum Dis. 2018;77(11):1692\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7600_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/bfm.2020.0068","volume":"15","author":"J Saito","year":"2020","unstructured":"Saito J, Yakuwa N, Ishizuka T, Goto M, Yamatani A, Murashima A. Belimumab concentrations in maternal serum and breast milk during breastfeeding and the safety assessment of the infant: A case study. Breastfeed Medicine: Official J Acad Breastfeed Med. 2020;15(7):475\u20137.","journal-title":"Breastfeed Medicine: Official J Acad Breastfeed Med"},{"issue":"5","key":"7600_CR41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.semarthrit.2021.06.005","volume":"51","author":"JH Kao","year":"2021","unstructured":"Kao JH, Lan TY, Lu CH, Cheng CF, Huang YM, Shen CY, et al. Pregnancy outcomes in patients treated with Belimumab: report from real-world experience. Semin Arthritis Rheum. 2021;51(5):963\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"7600_CR42","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"key":"7600_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/IJWH.S282604","volume":"14","author":"KH Dao","year":"2022","unstructured":"Dao KH, Bermas BL. Systemic lupus erythematosus management in pregnancy. Int J Women\u2019s Health. 2022;14:199\u2013211.","journal-title":"Int J Women\u2019s Health"},{"issue":"2","key":"7600_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/09612033221143286","volume":"32","author":"N Ghalandari","year":"2023","unstructured":"Ghalandari N, Crijns HJ, Dolhain RJ, Hazes JM, van Puijenbroek EP. Dilemma of Belimumab therapy (dis)continuation during pregnancy: results of a retrospective study in eudravigilance. Lupus. 2023;32(2):189\u201397.","journal-title":"Lupus"},{"issue":"2","key":"7600_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/ard-2022-222505","volume":"82","author":"M Petri","year":"2023","unstructured":"Petri M, Landy H, Clowse MEB, Gemzoe K, Khamashta M, Kurtinecz M, et al. Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from Belimumab clinical trials, a pregnancy registry and postmarketing reports. Ann Rheum Dis. 2023;82(2):217\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7600_CR46","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/09612033241245549","volume":"33","author":"P Vela-Casasempere","year":"2024","unstructured":"Vela-Casasempere P, Ca\u00f1o Alameda R, G\u00f3mez Sabater S, Cortell Aznar S, P\u00e9rez Pascual E. Considering Belimumab during pregnancy: A more viable option over time. Lupus. 2024;33(7):700\u201315.","journal-title":"Lupus"},{"issue":"4","key":"7600_CR47","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, et al. British society for rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: Immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62(4):e48\u201388.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7600_CR48","doi-asserted-by":"publisher","first-page":"e13888","DOI":"10.1111\/aji.13888","volume":"91","author":"H Yu","year":"2024","unstructured":"Yu H, Hu X, Huang X, Yin T, Liu L, Yue C, et al. Causal relationship between Circulating immune cells and recurrent spontaneous abortion: A bidirectional Mendelian randomization study. Am J Reproductive Immunol (New York NY: 1989). 2024;91(6):e13888.","journal-title":"Am J Reproductive Immunol (New York NY: 1989)"},{"key":"7600_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2019.08.002","volume":"214","author":"L Koushaeian","year":"2019","unstructured":"Koushaeian L, Ghorbani F, Ahmadi M, Eghbal-Fard S, Zamani M, Danaii S, et al. The role of IL-10-producing B cells in repeated implantation failure patients with cellular immune abnormalities. Immunol Lett. 2019;214:16\u201322.","journal-title":"Immunol Lett"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07600-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:02:23Z","timestamp":1745251343000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07600-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7600"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07600-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective case-control study was approved by the ethics committee of Qingdao Jinhua Gynecology Hospital. All subjects were treated with standard care without intervention from this study. All data were obtained via electronic medical records and a database review and were de-identified (all patients\u2019 name were replaced with an identification code, and all patients\u2019 private information were deleted before the analysis) to protect patient privacy, therefore all patients\u2019 informed consents are waived in accordance with national regulations, specifically the Measures for Ethical Review of Biomedical Research Involving Humans issued by the National Health Commission of China. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study used de-identified patient data, and no individual identifiable details are presented. According to institutional guidelines, consent for publication was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}